Wanqing Iris Zhi

Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell Carcinoma

Sean M. McBride, Eric J. Sherman, C. Jillian Tsai et al. · Journal of Clinical Oncology · 2020 · 394 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells

Chuanzhao Zhang, Wanqing Iris Zhi, Haiquan Lu et al. · Oncotarget · 2016 · 268 citations · Full text

Medicine, Molecular Biology, Oncology +14

Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study

C. Jillian Tsai, Zhigang Zhang, Wanqing Iris Zhi · The Lancet · 2023 · 255 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Cancers of the Appendix: Review of the Literatures

Carl Alex Ruoff, Louay Hanna, Wanqing Iris Zhi et al. · ISRN Oncology · 2011 · 104 citations · Full text

Medicine, Oncology, Surgery +15

Effect of Acupuncture vs Sham Procedure on Chemotherapy-Induced Peripheral Neuropathy Symptoms

Ting Bao, Sujata Patil, Connie Chen et al. · JAMA Network Open · 2020 · 100 citations · Full text

Medicine, Neurology, Oncology +9